Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.

McCravy MS, Quinney NL, Cholon DM, Boyles SE, Jensen TJ, Aleksandrov AA, Donaldson SH, Noone PG, Gentzsch M

Open source

DOI
10.1183/13993003.00062-2020
Published
2020 Jul
Container
The European respiratory journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1183/13993003.00062-2020,
  title = {Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.},
  author = {McCravy MS and Quinney NL and Cholon DM and Boyles SE and Jensen TJ and Aleksandrov AA and Donaldson SH and Noone PG and Gentzsch M},
  year = {2020},
  journal = {The European respiratory journal},
  doi = {10.1183/13993003.00062-2020},
  url = {https://doi.org/10.1183/13993003.00062-2020}
}

RIS

TY  - JOUR
TI  - Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.
AU  - McCravy MS
AU  - Quinney NL
AU  - Cholon DM
AU  - Boyles SE
AU  - Jensen TJ
AU  - Aleksandrov AA
AU  - Donaldson SH
AU  - Noone PG
AU  - Gentzsch M
PY  - 2020
JO  - The European respiratory journal
DO  - 10.1183/13993003.00062-2020
UR  - https://doi.org/10.1183/13993003.00062-2020
ER  - 

APA

MS, M., NL, Q., DM, C., SE, B., TJ, J., AA, A., SH, D., PG, N., & M, G. (2020). Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.. The European respiratory journal. https://doi.org/10.1183/13993003.00062-2020

Source records